These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 13735502)

  • 1. [Studies on conditions for paper chromatography of erythromycin].
    PIECHOWSKA M; OSTROWSKA-KRYSIAK B
    Med Dosw Mikrobiol; 1961; 13():167-72. PubMed ID: 13735502
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of degradation products in a topical gel containing erythromycin and benzoyl peroxide by liquid chromatography-mass spectrometry.
    Haghedooren E; Raju V S KK; Dehouck P; Govaerts C; Schepdael AV; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2006 Apr; 41(1):165-75. PubMed ID: 16377117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of stable and taste-free erythromycin proprodrugs.
    Bhadra PK; Morris GA; Barber J
    J Med Chem; 2005 Jun; 48(11):3878-84. PubMed ID: 15916440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allylation of erythromycin derivatives: introduction of allyl substituents into highly hindered alcohols.
    Stoner EJ; Peterson MJ; Allen MS; DeMattei JA; Haight AR; Leanna MR; Patel SR; Plata DJ; Premchandran RH; Rasmussen M
    J Org Chem; 2003 Nov; 68(23):8847-52. PubMed ID: 14604353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principal component analysis of nonlinear chromatography.
    Pate ME; Turner MK; Thornhill NF; Titchener-Hooker NJ
    Biotechnol Prog; 2004; 20(1):215-22. PubMed ID: 14763845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of a liquid chromatography-ultraviolet method with a non-volatile eluent, peak trapping and a liquid chromatography-mass spectrometry method with a volatile eluent to characterise erythromycin related substances.
    Pendela M; Van den Bossche L; Hoogmartens J; Van Schepdael A; Adams E
    J Chromatogr A; 2008 Feb; 1180(1-2):108-21. PubMed ID: 18177878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel fluorinated erythromycin antibiotic.
    Goss RJ; Hong H
    Chem Commun (Camb); 2005 Aug; (31):3983-5. PubMed ID: 16075093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric erythromycins: a comparison of the properties of erythromycins A and B 2'-ethyl succinates.
    Hassanzadeh A; Gorry PA; Morris GA; Barber J
    J Med Chem; 2006 Oct; 49(21):6334-42. PubMed ID: 17034139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual intramolecular hetero-Diels-Alder cycloaddition.
    Stoner EJ; Allen MS; Christesen AC; Henry RF; Hollis LS; Keyes R; Marsden I; Rehm TC; Shiroor SG; Soni NB; Stewart KD
    J Org Chem; 2005 Apr; 70(8):3332-5. PubMed ID: 15823010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimicrobial activity of erythromycin-A oxime analogs.
    Pandey D; Katti SB; Haq W; Tripathi CK
    Bioorg Med Chem; 2004 Jul; 12(14):3807-13. PubMed ID: 15210147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the adsorption kinetics of erythromycin onto neutral and anionic resins.
    Ribeiro MH; Ribeiro IA
    Bioprocess Biosyst Eng; 2003 Nov; 26(1):49-55. PubMed ID: 14505163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism for the degradation of erythromycin A and erythromycin A 2'-ethyl succinate in acidic aqueous solution.
    Hassanzadeh A; Barber J; Morris GA; Gorry PA
    J Phys Chem A; 2007 Oct; 111(40):10098-104. PubMed ID: 17880049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase transformations of erythromycin A dihydrate during pelletisation and drying.
    Römer M; Heinämäki J; Miroshnyk I; Sandler N; Rantanen J; Yliruusi J
    Eur J Pharm Biopharm; 2007 Aug; 67(1):246-52. PubMed ID: 17270405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of derivatives of (9S) -9-hydroxyl-12-methylene erythromycin A and their antibacterial activity in vitro].
    Xu P; Yang Y; Shi Y; Lei PS; Liu L
    Yao Xue Xue Bao; 2007 May; 42(5):497-501. PubMed ID: 17703771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A colorimetric method for the determination of erythromycin].
    KORCHAGIN VB; SEMENOV SM; SAVUSHKINA LN
    Antibiotiki; 1961 Apr; 6():311-4. PubMed ID: 13753122
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kinetics of the inactivation of erythromycin in aqueous solutions].
    KONDRAT'EVA AP; VAKULENKO NA; TEBIAKINA AE; BRUNS BP
    Antibiotiki; 1961 Jun; 6():541-7. PubMed ID: 13752922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of biological activity of erythromycin in all stages of its production].
    TEBIAKINA AE; SEMENOV SM
    Antibiotiki; 1959; 4():33-7. PubMed ID: 13837248
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistance of erythromycin in aqueous solutions].
    KONDRAT'EVA AP; BRUNS BP
    Antibiotiki; 1962 Jun; 7():511-4. PubMed ID: 14458180
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation and identification of a novel impurity of erythromycin A 9-oxime desosaminehydrazinium salt.
    Zhou CC; Huang X; Ford KL; Hollis LS
    J Antibiot (Tokyo); 2005 Aug; 58(8):539-44. PubMed ID: 16266129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-N,N-Dimethylamino-3-deoxy lincomycin: a structure-based hybrid between lincomycin and the desosamine unit of erythromycin.
    Hanessian S; Kothakonda KK
    Bioorg Med Chem; 2005 Sep; 13(17):5283-8. PubMed ID: 15994084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.